Abstract
A typical human cell expresses only a few thousand of the more than 30 000 genes contained within our chromosomes. The chromosomal infrastructure is essential for gene control, determining both active and repressed states. It is important not only to turn the right genes on but also to turn the right genes off. Histones and chromatin components have key roles in this decision making process. Mistakes have severe consequences. If as few as three inappropriate genes are turned off, a normal cell can be converted into a cancer cell. This epigenetic silencing of genes underlies a new approach to cancer therapy. Advances in the biochemistry and genetics of chromatin remodeling reveal that gene inactivation depends on the recruitment of enzymes that control the display of DNA within the chromosome. Mistargeting of these enzymes leads to tumorigenesis, but inhibition of their activity presents a novel approach to therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barton MC, Crowe AJ . 2001 Oncogene this issue.
Berger SL . 2001 Oncogene this issue.
Demeret C, Vassetzky Y, Mechali M . 2001 Oncogene this issue.
Derro BJ, Archer TK . 2001 Oncogene this issue.
Dilworth FJ, Chambon P . 2001 Oncogene this issue.
Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel- Belan A . 2001 Oncogene this issue.
Germond JE, Hirt P, Oudet P, Gross-Bellard M, Chambon P . 1975 Proc. Natl. Acad Sci. USA 72: 1843–1847
Grange T, Cappabianca L, Flavin M, Sassi H, Thomassin H . 2001 Oncogene this issue.
Hans F, Dimitrov S . 2001 Oncogene this issue.
Hebbes TR, Thorne AW, Crane-Robinson C . 1988 EMBO J. 7: 1395–1402
Herskowitz I, Andrews B, Kruger W, Orgas J, Sil A, Coburn C, Peterson C . 1992 In Transcription Regulation Vol 2, eds S McKnight and K Yamamoto Cold Spring Harbor Press: New York pp. 949–974
Imhof A, Yang XJ, Ogryzko VV, Nakatani Y, Wolffe AP, Ge H . 1997 Curr. Biol. 7: 689–692
Kruger W, Peterson CL, Sil A, Coburn C, Arents G, Moudrianakis EN, Herskowitz I . 1995 Genes Dev. 9: 2770–2779
Lee DY, Hayes JJ, Pruss D, Wolffe AP . 1993 Cell 72: 73–84
Liu PQ, Rebar EJ, Zhang J, Liu Q, Jamieson AC, Liang Y, Qi H, Li PX, Chen B, Mendel MC, Zhong X, Lee YL, Eisenberg S, Spratt SK, Case CC, Wolffe AP . 2001 J. Biol. Chem. in press
Mahmoudi T, Verrijzer CP . 2001 Oncogene this issue.
Minucci S, Nervi C, Lo Coco F, Pelicci PG . 2001 Oncogene this issue.
Muchardt C, Yaniv M . 2001 Oncogene this issue.
Nightingale KP, Wellinger RE, Sogo JM, Becker PB . 1998 EMBO J. 17: 2865–2876
Pandolfi PP . 2001 Oncogene this issue.
Perlmann T, Wrange O . 1988 EMBO J. 7: 3073–3083
Richard-Foy H, Hager GL . 1987 EMBO J. 6: 2321–2328
Rietveld LEG, Caldenhoven E, Stunnenberg HG . 2001 Oncogene this issue.
Robertson KD . 2001 Oncogene this issue.
Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP . 2001 Nature Genet. 25: 338–342
Rountree MR, Bachman KE, Herman JG, Baylin SB . 2001 Oncogene this issue.
Sogo JM, Stahl H, Koller T, Knippers R . 1986 J. Mol. Biol. 189: 189–204
Stallcup MR . 2001 Oncogene this issue.
Tse C, Sera T, Wolffe AP, Hansen JC . 1998 Mol. Cell. Biol. 18: 4629–4638
Ura K, Hayes JJ, Wolffe AP . 1995 EMBO J. 14: 3752–3765
Ura K, Kurumizaka H, Dimitrov S, Almouzni G, Wolffe AP . 1997 EMBO J. 16: 2096–2107
Urnov FD, Wolffe AP . 2001 Oncogene this issue.
Varga-Weisz P . 2001 Oncogene this issue.
Vetesse-Dadey M, Grant PA, Hebbes TR, Crane-Robinson C, Allis CD, Workman JL . 1996 EMBO J. 15: 2508–2518
Wade P . 2001 Oncogene this issue.
Waterborg JH . 2000 J.Biol.Chem. 275: 13007–13011
Wolffe AP . 1998 Chromatin: structure and function. 3rd Edition Academic Press
Wolffe AP, Brown DD . 1986 Cell 47: 217–227
Zhang HS, Dean DC . 2001 Oncogene this issue.
Zhang L, Spratt SK, Liu Q, Johnstone B, Qi H, Raschke EE, Jamieson AC, Rebar EJ, Wolffe AP, Case CC . 2000 J. Biol. Chem. 275: 33850–33860
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolffe, A. Chromatin remodeling: why it is important in cancer. Oncogene 20, 2988–2990 (2001). https://doi.org/10.1038/sj.onc.1204322
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204322
Keywords
This article is cited by
-
Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy
Holistic Integrative Oncology (2023)
-
Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells
Oncogene (2016)
-
Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck
Irish Journal of Medical Science (1971 -) (2015)
-
Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma
Tumor Biology (2014)
-
Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker
Tumor Biology (2014)